Abstract
Intra-articular steroid (IAS) injections are a safe and effective therapy in the management of Juvenile Idiopathic Arthritis (JIA). Timely access to joint injections, including appropriate anaesthesia, is now considered standard of care in the treatment of JIA. Despite this, little is known about the resource burden created by IAS provision. Published data is also lacking to inform families of the likely role that IAS will play in the management of their child’s disease.
Highlights
Intra-articular steroid (IAS) injections are a safe and effective therapy in the management of Juvenile Idiopathic Arthritis (JIA)
Little is known about the resource burden created by IAS provision
All patients with Juvenile Idiopathic Arthritis who attended the Royal Children’s Hospital, Melbourne, over a 5 year period between 1 January 2009 and 31 December 2013 were identified using our computerised database. This is a comprehensive clinical tool coded in Microsoft Access, which is used to record all Rheumatology patient demographics, contacts, procedures, communications and therapies
Summary
Intra-articular steroid (IAS) injections are a safe and effective therapy in the management of Juvenile Idiopathic Arthritis (JIA). Access to joint injections, including appropriate anaesthesia, is considered standard of care in the treatment of JIA. Little is known about the resource burden created by IAS provision. Published data is lacking to inform families of the likely role that IAS will play in the management of their child’s disease
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
